AZN Oct 2024 65.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 10:41AM EDT
| Previous close | 0.4300 |
| Open | 0.4300 |
| Bid | 0.4600 |
| Ask | 0.5100 |
| Strike | 65.00 |
| Expiry date | 2024-10-18 |
| Day's range | 0.4300 - 0.4300 |
| Contract range | N/A |
| Volume | |
| Open interest | 564 |
ZacksPharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
Simply Wall St.Here's Why We Think AstraZeneca (LON:AZN) Is Well Worth Watching
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Business WireAstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
WILMINGTON, Del., May 23, 2024--AstraZeneca and Alexion, AstraZeneca Rare Disease, will showcase 14 studies, including real-world evidence (RWE), from their portfolio and pipeline of investigational amyloidosis therapies at the International Symposium on Amyloidosis (ISA), in Rochester, MN from May 26–30, 2024.
© 2024 Yahoo. All rights reserved.